Beth C. Seidenberg, Director at Vera Therapeutics, Inc. (VERA), bought 622,156 shares at $7.08 ($4.4M) on 2023-02-07, disclosed to the SEC on 2023-02-09.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $7.24 | 46,163 | $334K | 7.6% |
| 2 | $7.24 | 46,163 | $334K | 7.6% |
| 3 | $7.03 | 131,602 | $925K | 20.9% |
| 4 | $7.03 | 131,602 | $925K | 20.9% |
| 5 | $7.08 | 87,956 | $623K | 14.1% |
| 6 | $7.08 | 87,956 |
| $623K |
| 14.1% |
| 7 | $7.22 | 45,357 | $327K | 7.4% |
| 8 | $7.22 | 45,357 | $327K | 7.4% |
| Total | $7.10 avg | 622,156 | $4.4M | 100% |
| Filing → |
| VERA | SELL | 2024-09-20 | $1.3M | — | Filing → |
| SGMT | BUY | 2023-07-20 | $750K | — | Filing → |
| SLRN | BUY | 2023-05-11 | $23.6M | — | Filing → |